A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort ® 160/4.5 in Healthy Volunteers Without Charcoal Block

Conditions:   Asthma;   COPD Interventions:   Drug: Budesonide;   Drug: Formoterol Sponsor:   Intech Biopharm Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials